|
Real-time
Oslo Bors
10:25:29 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 3.380 NOK | +2.74% |
|
+4.67% | +39.30% |
| 08-06 | Nykode Therapeutics Asa Announces Appointment of Jakob Helding Rasmussen as Chief Technology Officer | CI |
| 08-04 | Nykode Therapeutics Flags Delay in Draft Recommendation for Tax Appeal in Norway | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NYKODE THERAPEUTICS | Bio Therapeutic Drugs | +2.74% | +4.67% | +39.30% | +100.00% | -95.44% | 113M |  |  | |
- Stock Market
- Stocks
- VACC Stock
- Charts Nykode Therapeutics
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
